DYN Dyne Therapeutics, Inc.
Price Chart
Executive Summary
Two directors at Dyne Therapeutics (DYN) sold over $11.4 million in shares over the past 7 days, including a $4.3 million sale by Dirk Kersten on April 17. The cluster represents more than 0.35% of the company's $3.2B market cap, signaling notable insider selling.
Key Financial Metrics
Actionable Insight
Sustained, high-value insider selling by multiple directors raises concerns about confidence in near-term prospects. Traders should monitor upcoming clinical trial updates or regulatory filings for catalysts that may explain the divestment, and watch for downward pressure on the stock.
Key Facts
- Director Dirk Kersten sold 211,974 shares on April 17 for $4.3 million, the largest single transaction in the cluster.
- Director Jason Rhodes sold 143,175 shares across two days (April 21 and 22) for $2.83 million.
- Total insider selling over 7 days amounts to $11.4 million across 7 transactions by two directors.
- All transactions were open-market sales (code S), indicating deliberate divestment.
- Recent insider activity over the past 30 days totals $13.4 million in sales, suggesting sustained selling pressure.
Financial Impact
$11.4 million in insider sales over 7 days (0.35% of $3.2B market cap)
Risk Factors
- Loss of insider confidence may signal upcoming negative developments or lack of upside catalysts.
- Heavy selling could precede downward earnings or pipeline updates.
- Potential for increased share volatility if retail investors react to insider moves.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DYN-1776975352606 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
3d ago
|
Press Release
| $17.60 awaiting T+5 | awaiting T+5 | — | $17.37 (−1.31%) |
|
May 20, 2026
3d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 13, 2026
10d ago
|
144
| — | awaiting T+5 | — | — |
|
May 13, 2026
10d ago
|
144
| — | awaiting T+5 | — | — |
|
May 11, 2026
12d ago
|
8-K
| $18.46 $16.54 | ▼ −10.40% | ▼ −10.32% | $17.37 (−5.90%) |
|
May 6, 2026
17d ago
|
144
| $17.54 $18.44 | ▲ +5.13% | ▲ +3.63% | $17.37 (−0.97%) |
|
May 6, 2026
17d ago
|
144
| $17.54 $18.44 | ▲ +5.13% | ▲ +3.63% | $17.37 (−0.97%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access